Kristen Coppock, MA, Managing Editor

Oscar-winner Tom Hanks conveyed his appreciation for health care workers and encouraged people to follow protocols recommended by health experts in an effort to prevent the spread of COVID-19 during a live interview Monday hosted by ASHP.

Pharmacy schools are training students to recognize a mental health crisis and take action.

Ardon Health patients with autoimmune conditions have expressed common questions and concerns about COVID-19.

Kelly said life experiences, including his son's rare disease and death, are what ultimately prepared him to deal with cancer.

The specialty pipeline continues to grow at a rapid pace with a number of FDA approvals in 2019 for either new therapies or first in class for certain conditions, and many more drugs in development.

Recent studies have analyzed how individuals with autoimmune conditions prescribed specialty medications may be affected by the COVID-19 pandemic.

There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.

Buffalo Bills Hall of Fame quarterback Jim Kelly shared with specialty pharmacists his story of perseverance, tincluding his fight against squamous cell carcinoma in his upper jaw.

Amid rising cancer care costs, a focus on chemotherapy stewardship may result in cost savings, according to a session of the HOPA Practice Management 2020 Virtual Learning Event.

A first-in-class targeted therapy, VB-111 is administered by intravenous infusion once every 6 to 8 weeks.

Risdiplam is the first at-home, orally administered treatment for spinal muscular atrophy in adults and children aged 2 months and older.

Gilead Sciences is increasing the global supply of the investigational drug remdesivir in preparation for demand in fighting COVID-19.

These study results were announced by Eisai and Merck during the 2020 American Society of Clinical Oncology Virtual Scientific Program, May 29-31.

The COVID-19 pandemic has revealed structural inequalities in health care and has brought many issues of health equality to the forefront of public consciousness.

FreeStyle Libre continuous glucose monitoring (CGM) technology was linked with significant reduction in hemoglobin A1c levels for people living with type 2 diabetes on either long-acting insulin or non-insulin therapy.

Managing diabetes in rural areas is difficult due to limited access to specialty care and self-management programs.

The investigational, marine-derived small-molecule binds to and affects the function of the protein tubulin within cells of the body.

The EUAs are in place for the duration of the coronavirus disease 2019 (COVID-19) pandemic.

The recent analysis of VB-111 was a phase 3 potential registration study conducted with 400 patients and 95 sites around the world.

The results of the new study were presented during the virtual scientific program of the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting.

The recent analysis studied 400 patients with thoracic cancers who received chemotherapy within 3 months of being diagnosed with COVID-19.

Trastuzumab deruxtecan (T-DXd) (Enhertu) demonstrated strong efficacy in a phase 2 trial for treatment of HER2-positive metastatic breast cancer.

Treatment with avelumab (Bavencio) potentially cured 8 of 15 women in a trial with gestational trophoblastic tumors resistant to single-agent chemotherapy.

Oriahnn is the first FDA-approved nonsurgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women

Atezolizumab (Tecentriq) approved in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.

FDA has granted Fast Track designation to Cardiff Oncology’s onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

The FDA approval of solifenacin succinate marks the first for the treatment of young pediatric patients with NDO.

The NASP Challenge is an unique opportunity to identify innovative ideas and creative solutions focused on enhancing the specialty pharmacy patient jouney.

The impact of COVID-19 on pharmacy has been significant in the short-term, and recent developments have shown that there is opportunity for that to translate into long-term changes for the industry.

Despite the rate of HIV infection in adolescents and young adults, a study found that PrEP awareness is limited.